Campath and Convulsion - a phase IV clinical study of FDA data

Summary:

Convulsion is reported as a side effect among people who take Campath (alemtuzumab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Fludara, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Convulsion when taking Campath. It is created by eHealthMe based on reports of 4,897 people who have side effects when taking Campath from the FDA, and is updated regularly.

What is Campath?

Campath has active ingredients of alemtuzumab. eHealthMe is studying from 4,909 Campath users. Check the latest studies of Campath.

What is Convulsion?

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body) is found to be associated with 1,864 drugs and 2,856 conditions by eHealthMe. Check the latest studies of Convulsion.

On Jul, 06, 2026

4,897 people reported to have side effects when taking Campath.
Among them, 50 people (1.02%) have Convulsion.

Among these 50 people:

How long have people been on Campath when they have Convulsion? *

What is the gender of people who have Convulsion when taking Campath? *

female: 26.83 %
male: 73.17 %

What is the age of people who have Convulsion when taking Campath? *

What are other drugs people take besides Campath? *

What are other side effects people have besides Convulsion? *

High Blood Pressure: 8 people, 16.00%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 7 people, 14.00%
Perineal Ulceration: 7 people, 14.00%
Meningitis Viral (viral inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 5 people, 10.00%
Drowsiness: 5 people, 10.00%
Fever: 4 people, 8.00%
Acute Kidney Failure: 4 people, 8.00%
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch): 4 people, 8.00%
Brain Herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull): 4 people, 8.00%
Consciousness - Decreased: 4 people, 8.00%

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 16 people, 32.00%
Combined Immunodeficiency: 7 people, 14.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 8.00%
Malignant Histiocytosis (cancerous increase in the number of immune cells): 3 people, 6.00%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 4.00%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 1 person, 2.00%
Chronic Lymphocytic Leukaemia Recurrent (repeated cancer of blood cells known as lymphocytes): 1 person, 2.00%
Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 1 person, 2.00%
Constipation: 1 person, 2.00%
Diabetes: 1 person, 2.00%

* Approximation only. Some reports may have incomplete information.

Do you take Campath and have Convulsion?

- Check whether Convulsion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Campath:

Campath (4,909 reports)

Convulsion treatments and more:

Convulsion (99,535 reports)

Browse all side effects of Campath:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Convulsion:

Convulsion (1,864 drugs)

Browse all the conditions that are associated with Convulsion:

Convulsion (2,856 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alemtuzumab (the active ingredients of Campath) and Campath (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.